Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience

INTRODUCTION: Hepatitis C virus (HCV) infection has detrimental effects on patient and graft survival after kidney transplantation. In the pre‐direct‐acting antiviral (DAA) era, treatment of HCV infection was associated with low response rates, poor tolerance, and increased risk of allograft rejecti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Immun Inflamm Dis
Päätekijät: Alkadi, Mohamad M., Abuhelaiqa, Essa A., Elshirbeny, Mostafa F., Hamdi, Ahmed F., Fituri, Omar M., Asim, Muhammad, Alkaabi, Saad R., Derbala, Moutaz F., Jarman, Mona E., Ashour, Adel M., Nauman, Awais, Al Maslamani, Yousuf K., Butt, Adeel A., Al‐Malki, Hassan A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7860605/
https://ncbi.nlm.nih.gov/pubmed/33264509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iid3.386
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia